Intrinsic Value
Theravance Biopharma, Inc. (TBPH)
$9.34
+0.14 (+1.52%)
| Enterprise Value | -2,142.96 |
|---|---|
| Net Debt | 5.69 |
| Equity Value | -2,148.66 |
| Shares Outstanding | 55.30 |
| Equity Value Per Share | -38.85 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt